Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study: Investigating a Novel Supplement-based Therapy for the Treatment of Small Intestinal Bacterial Overgrowth

NCT03420976 is registered in ClinicalTrials.gov with Atrium Innovations as lead sponsor.

NCT NCT03420976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03420976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study: Investigating a Novel Supplement-based Therapy for the Treatment of Small Intestinal Bacterial Overgrowth
Lead sponsor
Atrium Innovations
Phase
Phase 1
Overall status
Withdrawn
Start date
December 7, 2017
Completion date
February 1, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

small intestinal bacterial overgrowth